Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID2191 | SLDFTELDVAAEK | Angiotensinogen | Serum | 1436.70349 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID3215 | IDRFMQAVTGW | Angiotensinogen | Plasma | 1322.6441 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3216 | SLDFTELDVAAEK | Angiotensinogen | Plasma | 1436.7035 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3217 | IDRFMQAVTGWK | Angiotensinogen | Plasma | 1450.7391 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3218 | ANAGKPKDPTFIPAPIQA | Angiotensinogen | Plasma | 1834.9941 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3219 | QPFVQGLALYTPVVLPR | Angiotensinogen | Plasma | 1897.0826 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3220 | TSPVDEKALQDQLVLVAAKLDTEDK | Angiotensinogen | Plasma | 2725.4386 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3221 | TSPVDEKALQDQLVLVAAKLDTEDKL | Angiotensinogen | Plasma | 2838.5226 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3222 | TSPVDEKALQDQLVLVAAKLDTEDKLR | Angiotensinogen | Plasma | 2994.6237 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID4398 | AVFGTLASLYLGALDHTADRLQAI | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4421 | AVYDQSATALHFLGRVANPL | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4422 | AVYDQSATALHFLGRVANPLSTA | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5321 | GVFTAPGLHLKQPFVQGLALYTPV | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5388 | HLTMPQLVLQGSYDLQDLLAQAELPA | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6012 | LQGSYDLQDLLAQAELPA | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6013 | LQGSYDLQDLLAQAELPAILHT | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7007 | SLYLGALDHTADRLQAI | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7345 | TALHFLGRVANPLSTA | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7429 | TGWKTGCSLMGASVDS | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7506 | TLNRPFLFAV | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7507 | TLNRPFLFAVYDQSA | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7508 | TLNRPFLFAVYDQSAT | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7850 | VGVFTAPGLHLKQPFVQGLALYTPV | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7910 | VLPRSLDFTELDVAAEKI | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7911 | VLQGSYDLQDLLAQAEL | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7912 | VLQGSYDLQDLLAQAELPAIL | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8085 | VVGVFTAPGLHLKQPFVQGLAL | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8137 | WGVVHGATVLSPT | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8252 | YDQSATALHFLGRVANPLS | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8253 | YDQSATALHFLGRVANPLSTA | Angiotensinogen | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8685 | AELPAILHTEL | Angiotensinogen | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8747 | DFTELDVAAEK | Angiotensinogen | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8796 | ELPAILHTEL | Angiotensinogen | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8847 | FTELDVAAEK | Angiotensinogen | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9011 | LDFTELDVAAEK | Angiotensinogen | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9098 | NKPEVLEVTLN | Angiotensinogen | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9324 | TPVVLPRSLDFTELDVAAEK | Angiotensinogen | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID10063 | DRVYIHPFHL | Angiotensinogen | Urine | 1296.6753 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10598 | FAVYDQSATALHFLGRVANPLSTA | Angiotensinogen | Urine | 2549.3048 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |